






Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
This document defines adverse drug reactions (ADR) and its types. It explains the criteria for causality assessment of ADR and the classification of severity, frequency, and reaction time. It also presents the Rawling-Thompson classification of ADR, which includes fixed dose eruptions, bizarre non-dose related, and genetic/immunological types. The document further discusses the dose-related (type A) and non-dose related (type B) ADR, their incidence, predictability, prevention, and treatment.
Typology: Slides
1 / 12
This page cannot be seen from the preview
Don't miss anything!
An adverse drug reaction is any response to the drug which is noxious & unintended and which occurs at doses used in man for prophylaxis, diagnosis or therapy or modification of physiological functions (WHO Technical Report No 498, 1972) excludes
Side Effects “Any unintended effect of pharmaceutical product occurring at doses normally used in man , which is related to pharmacological properties of the drug” Adverse Event “An unwanted medical occurrence that may present during treatment with pharmaceutical product but which does not necessarily have a causal relationship with this treatment”
Mild: No antidote No change in treatment No prolonged stay in hospital Moderate: May require change in treatment May require specific treatment May prolong stay in hospital Severe: Life threatening/ Permanent disability Discontinuation of drug is must Require specific treatment Lethal: Death directly/indirectly contributes to death
Fixed Dose Eruptions: Type B (Type II) Bizarre Non-dose related Unpredictable Serious, Rare Need stoppage of drug. Genetic/immunological
Dose related (type A) ❖ 95 % incidence ❖ predictable ❖ Extension & severity are related to conc. of drug ❖ Prevention and treatment by adjustment of dose insulin- hypoglycemia Non- dose related (type B) ❖ 5 % incidence ❖ unpredictable ❖ Usually qualitative change ❖ Prevention difficult; ❖ done by avoidance ❖ discontinuation SLE with hydralazine